Listed

AIM ImmunoTech Inc.

AIMNYSECIK 946644HealthcareFiscal year ends Dec 31

Reports and events: 417 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

AIM ImmunoTech Inc., Reports and events
FiledFormWhat it isAccession number
2021-05-1807:30 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-21-012057
2021-05-1716:31 ET10-QQuarterly reportPeriod 2021-03-310001493152-21-011883
2021-05-0613:45 ET8-K8.01 Other events0001493152-21-010587
2021-05-0307:30 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-21-010295
2021-04-2316:45 ET8-K2.01 Completion of an acquisition or disposition; 8.01 Other events0001493152-21-009585
2021-04-1908:45 ET8-K1.01 Entry into a material agreement0001493152-21-009085
2021-04-0916:45 ET8-K8.01 Other events0001493152-21-008435
2021-04-0706:45 ET8-K1.01 Entry into a material agreement0001493152-21-008137
2021-03-3119:52 ET10-KAnnual reportPeriod 2020-12-310001493152-21-007259
2021-03-2308:55 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-21-006597
2021-03-2208:50 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-21-006488
2021-03-1016:05 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-21-005761
2021-03-0807:01 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-21-005524
2021-02-2409:15 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001493152-21-004685
2021-02-0512:00 ET8-K8.01 Other events0001493152-21-002721
2021-01-2906:55 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001493152-21-002059
2021-01-2207:30 ET8-K4.01 Change of auditor; 9.01 Financial statements and exhibits0001493152-21-001585
2020-12-2317:20 ET8-K1.01 Entry into a material agreement0001493152-20-024255
2020-12-1108:00 ET8-K5.02 Departure or appointment of officers or directors0001493152-20-023343
2020-11-2309:05 ET8-K7.01 Regulation FD disclosure0001493152-20-022193
2020-11-2017:25 ET8-K8.01 Other events0001493152-20-022140
2020-11-1216:45 ET10-QQuarterly reportPeriod 2020-09-300001493152-20-021121
2020-10-0716:52 ET8-K5.07 Shareholder vote results0001493152-20-019098
2020-10-0609:10 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001493152-20-018981
2020-10-0516:05 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-20-018915
2020-08-3113:09 ET8-K/A7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-20-016985
2020-08-3107:30 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-20-016968
2020-08-1417:03 ET10-QQuarterly reportPeriod 2020-06-300001493152-20-015932
2020-08-1117:23 ETDEF 14AProxy statementPeriod 2020-08-110001493152-20-015281
2020-08-0306:30 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-20-014436
2020-07-0907:00 ET8-K1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-20-012885
2020-07-0609:00 ET8-K1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-20-012600
2020-06-2409:00 ET8-K1.01 Entry into a material agreement; 8.01 Other events0001493152-20-011683
2020-06-1513:56 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-20-011151
2020-06-0517:00 ET8-K1.01 Entry into a material agreement0001493152-20-010677
2020-05-1408:20 ET10-Q/AQuarterly report, amendedPeriod 2020-03-310001493152-20-008595
2020-05-1420:19 ET10-QQuarterly reportPeriod 2020-03-310001493152-20-008572
2020-04-2717:13 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001493152-20-007168
2020-04-1617:00 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-20-006554
2020-04-0617:16 ET8-K1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-20-005912
2020-03-3017:22 ET10-KAnnual reportPeriod 2019-12-310001493152-20-005290
2020-03-2608:15 ET8-K1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-20-004768
2020-03-2619:28 ET8-K5.02 Departure or appointment of officers or directors0001493152-20-004743
2020-03-0907:00 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-20-003568
2020-02-1806:45 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-20-002633
2020-02-1106:45 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-20-001904
2019-12-1106:30 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits0001493152-19-019007
2019-12-0406:35 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-19-018705
2019-11-1416:31 ET10-QQuarterly reportPeriod 2019-09-300001493152-19-017506
2019-10-1706:30 ET8-K5.02 Departure or appointment of officers or directors0001493152-19-015596

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 14, 2026, 11:22 ET. Listed shows no prices and gives no investment advice.